|Bid||154.37 x 100|
|Ask||157.54 x 100|
|Day's Range||154.55 - 155.50|
|52 Week Range||108.29 - 160.62|
|PE Ratio (TTM)||34.54|
|Forward Dividend & Yield||1.70 (1.10%)|
|1y Target Est||N/A|
In this article, I will take a look at Stryker Corporation’s (NYSE:SYK) most recent earnings update (30 September 2017) and compare these latest figures against its performance over the pastRead More...
The last change in the short interest score occurred more than 1 month ago and implies that there has been little change in sentiment among investors who seek to profit from falling equity prices. Index (PMI) data, output in the Healthcare sector is rising.
ZBH stock has a “buy” rating from 18 (64%) analysts. Nine (32%) analysts gave ZBH a “hold” rating, and one gave it a “sell” rating.
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Stryker Corp. Here are 5 ETFs with the largest exposure to SYK-US. Comparing the performance and risk of Stryker Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Stryker shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 81.
Stryker (SYK) announced its 3Q17 earnings results on October 26, 2017. In this article, we’ll look at analysts’ ratings, recommendations, and target prices for Stryker over the next 12 months.…
Stryker (SYK) released its 3Q17 earnings results on October 26, 2017. The company increased its fiscal 2017 guidance during the earnings release. Let’s have a look at the company’s updated…
On October 24, 2017, Stryker (SYK) acquired the majority share capital of Vexim. The acquisition of a controlling stake in Vexim has provided Stryker with an expanded portfolio of minimally…
On September 1, 2017, Stryker completed the acquisition of Novadaq Technologies. The company announced the deal on June 19, 2017. For details on the announcement, read Stryker Acquires Novadaq, Enhances…...
Categories: Yahoo FinanceGet free summary analysis Stryker Corp. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Stryker Corp. – Edwards Lifesciences Corporation, Boston Scientific Corporation, Baxter International Inc., Integra LifeSciences Holdings Corporation and Exactech, Inc. (EW-US, BSX-US, BAX-US, IART-US and EXAC-US) that have also reported ... Read more (Read more...)
In 3Q17, Stryker sold 33 Mako robots, compared with 30 robots in 3Q16. In 2Q17, Stryker installed 26 Mako robots. Of these 33 robots, 23 were installed in the United States.…
Stryker (SYK) announced its 3Q17 earnings results on October 26, 2017. The company registered adjusted diluted EPS (earnings per share) of $1.52, surpassing the Wall Street estimate of $1.50. The…
Stryker (SYK) has reported its 3Q17 earnings results. All of its segments—Orthopaedics, MedSurg, and Neurotechnology and Spine—registered solid performance, with reported sales growth of around 5.1%, 6.7%, ...
On October 26, 2017, Stryker (SYK) reported its 3Q17 earnings results, exceeding analysts’ expectations. SYK stock opened trading ~5.6% higher than the company’s closing price of $148.96. Despite near-term ...
Stryker, one of the leading players in the orthopedic device industry, released its 3Q17 earnings results on October 26, 2017.
Stryker shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 76 to 82.
The Kalamazoo, Michigan-based company said it had net income of $1.14 per share. Earnings, adjusted for amortization costs and non-recurring costs, came to $1.52 per share. The results beat Wall Street ...
Investors are concerned about the Medical sector that saw a lot of struggle during the first nine months of the year, thanks to the political change and the ongoing policy-restructuring related battle.
According to analysts’ estimates, Stryker’s 3Q17 EPS will be ~$1.50. The estimate signifies YoY growth of ~7.6%—compared to EPS growth of 10.1% YoY in 2Q17.
On October 26, 2017, Stryker (SYK) will announce its 3Q17 earnings results. The company's revenue is expected to be ~$2.97 billion.
Stryker (SYK), the second-largest orthopedic device developer, is set to announce its 3Q17 earnings results on October 26, 2017.
In August, Stryker (SYK) announced a voluntary recall of the Oral Care line-up, which was offered by the company's Sage-Products unit.